Cas:81678-16-2 Leucine enkephalin manufacturer & supplier

Chemical Name:Leucine enkephalin

CAS.NO:81678-16-2

Synonyms:LEUCINE ENKEPHALIN SYNTHETIC ACETATE;Tyr-Gly-Gly-Phe-Leu*HOAc;LEUCINE ENKEPHALIN ACETATE SALT;TYR-GLY-GLY-PHE-LEU ACETATE SALT;Leucine Enkephalin hydrate acetate salt

Molecular Formula:C₃₀H₄₁N₅O₉

Molecular Weight:615.67500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:237.25000

Exact Mass:615.29000

LogP:2.19220

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like LEUCINE ENKEPHALIN SYNTHETIC ACETATE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Leucine Enkephalin hydrate acetate salt physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Leucine Enkephalin hydrate acetate salt Use and application,Leucine Enkephalin hydrate acetate salt technical grade,usp/ep/jp grade.

Related News: The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. Leucine enkephalin manufacturer Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed. Leucine enkephalin supplier Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday. Leucine enkephalin vendor Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday. Leucine enkephalin factory Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.